Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The SELECT trial showed that semaglutide 2.4 mg (Wegovy) reduces cardiovascular risk in adults with established cardiovascular disease and either overweight or obesity, leading to an FDA-approved indication for reducing cardiovascular risk in this population
These can help with satiety and overall health
Both Tirzepatide and Semaglutide can be effective for weight loss
We tailor dosing based on your needs and health history
Federal vs State Authority Federal Government: Sets minimum standards for telehealth Regulates interstate commerce Oversees FDA (medication approval) Manages DEA (controlled substances) HIPAA privacy requirements State Governments: License healthcare providers Regulate medical practice License pharmacies Set telehealth practice standards Control what can be prescribed remotely States have primary authority over medical practice, including telehealth
